| Gianirda Santiago, | |
|
4641 Pottsville Pike, Reading, PA 19605-9707 | |
| (484) 578-9796 | |
| Not Available |
| Full Name | Gianirda Santiago |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 4641 Pottsville Pike, Reading, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023737913 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gianirda Santiago, 218 N 2nd St, Reading, PA 19601-2902 Ph: (610) 507-1699 | Gianirda Santiago, 4641 Pottsville Pike, Reading, PA 19605-9707 Ph: (484) 578-9796 |
News Archive
The statistics on maternal, newborn, and child mortality around the world are staggering: 265,000 maternal deaths, 880,000 stillbirths, 1.2 million neonatal deaths, and 3.2 million infant and child deaths annually, the vast majority occurring in low-income countries.
China Shenghuo Pharmaceutical Holdings, a China-based pharmaceutical company engaged in the research, development, manufacture, and marketing of Traditional Chinese Medicine, nutritional supplement and cosmetic products, today announced that "Lixuwang", the trademark of its best selling product, Xuesaitong Capsule, was awarded the Chinese Well-Known Trademark Honor by the State Administration for Industry and Commerce of China.
The antibodies are capable of neutralizing a wide range of SARS-CoV-2 variants even at sub-nanomolar concentrations. In addition, the combinations of these antibodies reduce the risk of generating escape mutants in vitro. The study is published in the journal Science.
Curis, a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company has selected CUDC-907, an orally available, synthetic small molecule inhibitor of phosphatidylinositol-3-kinase and histone deacetylase as a development candidate from its targeted cancer programs.
› Verified 5 days ago
Brynne Alban, M.ED. Counselor Medicare: Not Enrolled in Medicare Practice Location: 938 Penn St, Reading, PA 19602 Phone: 610-478-8088 Fax: 610-478-4884 | |
Melanie Shuhler, B.S. Counselor Medicare: Not Enrolled in Medicare Practice Location: 3503 Romig Ave, Reading, PA 19606 Phone: 484-663-1875 | |
Iris N Garcia, MA Counselor Medicare: Not Enrolled in Medicare Practice Location: 645 Penn St Fl 2, Reading, PA 19601 Phone: 610-343-5721 | |
Lael Schwartz, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 150 Grandview Dr, Reading, PA 19607 Phone: 610-781-2071 | |
Lisa A Kasmari, MA Counselor Medicare: Not Enrolled in Medicare Practice Location: 125 S 5th St, Reading, PA 19602 Phone: 610-685-2188 Fax: 610-320-5442 | |
Sarah Walter, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2208 Quarry Dr Ste 200, Reading, PA 19609 Phone: 610-563-2052 |